229 related articles for article (PubMed ID: 11433409)
1. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears.
Rha SH; Dong SM; Jen J; Nicol T; Sidransky D
Int J Cancer; 2001 Aug; 93(3):424-9. PubMed ID: 11433409
[TBL] [Abstract][Full Text] [Related]
2. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
Uyar DS; Eltabbakh GH; Mount SL
Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
[TBL] [Abstract][Full Text] [Related]
3. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
4. The PapSpin: a reasonable alternative to other, more expensive liquid-based Papanicolaou tests.
Rosenthal DL; Geddes S; Trimble CL; Carson KA; Alli PM
Cancer; 2006 Jun; 108(3):137-43. PubMed ID: 16628656
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
6. Differentiated cervical intraepithelial neoplasia-associated invasive cervical squamous cell carcinoma as a source of major cytopathological and surgical pathological discrepancy in Papanicolaou smear screening tests.
Mai KT
Cytopathology; 2018 Apr; 29(2):143-149. PubMed ID: 29575422
[TBL] [Abstract][Full Text] [Related]
7. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
Mannino JR
J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
[TBL] [Abstract][Full Text] [Related]
8. Identification of progressive cervical epithelial cell abnormalities using DNA image cytometry.
Grote HJ; Nguyen HV; Leick AG; Böcking A
Cancer; 2004 Dec; 102(6):373-9. PubMed ID: 15526273
[TBL] [Abstract][Full Text] [Related]
9. Metastatic melanoma of the uterine cervix diagnosed on cervical Pap smear: Case report and literature review.
Shachner TR; Van Meter SE
Diagn Cytopathol; 2018 Dec; 46(12):1045-1049. PubMed ID: 30354020
[TBL] [Abstract][Full Text] [Related]
10. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
[TBL] [Abstract][Full Text] [Related]
12. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
[TBL] [Abstract][Full Text] [Related]
13. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
Upendram P; Sahni S; Mohiuddin K; Poornima S; Gourishankar B; Kumar Vattam K; Boddala P; Jayashankar E; Mohiuddin S; Kamineni V; Mohan V; Houldsworth J; Hasan Q
Tumour Biol; 2017 Oct; 39(10):1010428317698363. PubMed ID: 28990460
[TBL] [Abstract][Full Text] [Related]
14. Eleven-year review of data on Pap smears in Saudi Arabia: We need more focus on glandular abnormalities!
Nasser H; AlAyyaf M; Atallah A; Aminulislam M; Rizwan L; Aodah A; Alkahtani Y; Alshammari H; Alsayed A; Szpunar S
Ann Saudi Med; 2017; 37(4):265-271. PubMed ID: 28761025
[TBL] [Abstract][Full Text] [Related]
15. A comparison of liquid-based cytology and Pap smear as a screening method for cervical cancer.
Zhu J; Norman I; Elfgren K; Gaberi V; Hagmar B; Hjerpe A; Andersson S
Oncol Rep; 2007 Jul; 18(1):157-60. PubMed ID: 17549362
[TBL] [Abstract][Full Text] [Related]
16. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
Honarvar Z; Zarisfi Z; Salari Sedigh S; Masoumi Shahrbabak M
J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
[TBL] [Abstract][Full Text] [Related]
17. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
18. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
19. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population.
Cheung AN; Szeto EF; Leung BS; Khoo US; Ng AW
Cancer; 2003 Dec; 99(6):331-5. PubMed ID: 14681939
[TBL] [Abstract][Full Text] [Related]
20. Interpreting epithelial cell abnormalities detected during cervical smear screening--a cytohistologic approach.
Patel TS; Bhullar C; Bansal R; Patel SM
Eur J Gynaecol Oncol; 2004; 25(6):725-8. PubMed ID: 15597851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
